Skip to main content
. 2024 Feb 26;18:1288380. doi: 10.3389/fnins.2024.1288380

Table 2.

Basic characteristics of patients between groups.

Missing (n) CSVD group Control group p value
Number 71 29
Age (quartile), y 55.0 (50.0, 64.0) 54.0 (37.0, 58.5) 0.046
Male (n), % 0 62 (87.3) 22 (75.9) 0.156
Smoking (n), % 1 39 (55.7) 13 (44.8) 0.324
Alcohol consumption (n), % 1 35 (50.0) 11 (37.9) 0.273
BMI (x ± s) 25.4 ± 3.2 25.3 ± 3.5 0.884
Medical history of (n), %
CVD 1 9 (12.9) 3 (10.3) 0.727
HBP 1 49 (70.0) 11 (37.9) 0.003
DM 1 7 (10.0) 3 (10.3) 0.959
Hyperlipidemia 1 21 (30.0) 10 (34.5) 0.662
CI 1 2 (2.9) 0 (0.0) 0.358
SBP (x ± s), mmHg 148.2 ± 20.7 136.6 ± 17.9 0.010
DBP (x ± s), mmHg 87.1 ± 12.1 90.5 ± 14.5 0.274
GHb (quartile), % 5.8 (5.5, 6.1) 5.6 (5.4, 6.2) 0.380
FBG (quartile), mmol/l 4.7 (4.3, 5.1) 4.6 (4.2, 5.1) 0.356
LDL-C (quartile), mmol/l 2.0 (1.6, 2.6) 2.4 (1.5, 2.8) 0.646
MMSE (quartile) 77 27.0(22.0,28.2) 26.0(24.5,29.0) 0.691
MoCA (quartile) 78 21.6 ± 5.2 24.0 ± 3.7 0.399

BMI, body mass index; CVD, cerebrovascular disease; CI, cognitive impairment; SBP, systolic blood pressure; DBP, diastolic blood pressure; GHb, glycated hemoglobin; FBG, fasting blood glucose; LDL-C, low-density lipoprotein cholesterol.